These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 26355594)
1. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs. Lin YK; Yang SH; Chen CC; Kao HC; Fang JY PLoS One; 2015; 10(9):e0137890. PubMed ID: 26355594 [TBL] [Abstract][Full Text] [Related]
2. Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation. Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY Pharm Res; 2014 Feb; 31(2):382-93. PubMed ID: 24022680 [TBL] [Abstract][Full Text] [Related]
3. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities. Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894 [TBL] [Abstract][Full Text] [Related]
4. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles. Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151 [TBL] [Abstract][Full Text] [Related]
5. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay. Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586 [TBL] [Abstract][Full Text] [Related]
6. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice. Liang L; Fei WM; Zhao ZQ; Hao YY; Zhang C; Cui Y; Guo XD Eur J Pharm Biopharm; 2021 Jul; 164():20-27. PubMed ID: 33895291 [TBL] [Abstract][Full Text] [Related]
7. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells. Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999 [TBL] [Abstract][Full Text] [Related]
8. Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk. Lee WR; Shen SC; Aljuffali IA; Lin YK; Huang CW; Fang JY Eur J Pharm Sci; 2016 Sep; 92():1-10. PubMed ID: 27345564 [TBL] [Abstract][Full Text] [Related]
9. 8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model. Shirsath N; Wagner K; Tangermann S; Schlederer M; Ringel C; Kenner L; Brüne B; Wolf P Acta Derm Venereol; 2018 Jun; 98(6):576-584. PubMed ID: 29582898 [TBL] [Abstract][Full Text] [Related]
10. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335 [TBL] [Abstract][Full Text] [Related]
11. Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. Rai VK; Sinha P; Yadav KS; Shukla A; Saxena A; Bawankule DU; Tandon S; Khan F; Chanotiya CS; Yadav NP J Ethnopharmacol; 2020 Oct; 261():113127. PubMed ID: 32623016 [TBL] [Abstract][Full Text] [Related]
12. Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689 [TBL] [Abstract][Full Text] [Related]
13. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282 [TBL] [Abstract][Full Text] [Related]
14. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related]
15. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy. Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978 [TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308 [TBL] [Abstract][Full Text] [Related]
17. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model. Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338 [TBL] [Abstract][Full Text] [Related]
18. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice. Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis. Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833 [TBL] [Abstract][Full Text] [Related]
20. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis. Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]